This text is based on the recommendations accepted by the 4th Hungarian Consensus
Conference on Breast Cancer, modified on the basis of the international consultation
and conference within the frames of the Central-Eastern European Academy of Oncology.
The recommendations cover non-operative, intraoperative and postoperative diagnostics,
determination of prognostic and predictive markers and the content of cytology and
histology reports. Furthermore, they address some specific issues such as the current
status of multigene molecular markers, the role of pathologists in clinical trials
and prerequisites for their involvement, and some remarks about the future.
